Latest News

Tuesday, May 31, 2016 | Earnings & Financials, Allergan

Carl Icahn Acquires 'Large Position' in Allergan, Backs CEO

Billionaire investor Carl Icahn said on Tuesday he had acquired a "large position" in Botox-maker Allergan Plc (AGN.N) and that he was very supportive of Chief Executive Officer Brent Saunde…

Read the full story

Tuesday, May 31, 2016 | Product Releases

Orbis Unveils its Next Generation Flying Eye Hospital at LAX on Thursday

Orbis will unveil the third generation of its Flying Eye Hospital on board an MD-10 aircraft at the Los Angeles International Airport on June 2. Orbis operates the world’s only Flying Eye Hos…

Read the full story

Tuesday, May 31, 2016 | Management/Leadership, Valeant

Valeant's Former CEO Will Stay on as an $83,000-a-Month Consultant

Michael Pearson may have gotten sacked from Valeant Pharmaceuticals earlier this year, but he will still collect a paycheck. The former CEO, who led the company through the thick of its drug-price gou…

Read the full story

Tuesday, May 31, 2016 | Clinical Trials, Presbia

All Patients in Presbia Flexivue Microlens FDA Study Complete 6-Month Postoperative Visits

Presbia PLC announced that all 421 subjects treated with the Presbia Flexivue Microlens as part of its FDA pivotal study completed their 6-month postoperative visits, one step closer to making the sub…

Read the full story

Tuesday, May 31, 2016 | Clinical Trials, Pixium Vision

Pixium Vision Receives Clinical Trial Approval From UK Regulatory Authority for 150 Electrode IRIS II Bionic Vision System

Pixium Vision announced that it has received approval from the Medicines & Healthcare products Regulatory Agency (MHRA) in the UK to initiate a clinical trial for patients who have lost sight due …

Read the full story

Tuesday, May 31, 2016 | Medical Studies

Vitamin D Deficiency Linked to Diabetic Retinopathy

Diabetic retinopathy may be yet another ill effect associated with vitamin D deficiency, a new meta-analysis and systematic review suggests. The findings were presented May 27, 2016 here at the Americ…

Read the full story

Saturday, May 28, 2016 | Miscellaneous

Internationally Acclaimed Ophthalmologist and Former ESCRS President Peter Barry Dies

Peter Barry, FRCS, head of the Department of Ophthalmology in St Vincent’s University Hospital, Dublin, died on Thursday after a short illness. In a statement, the European Society of Catarac…

Read the full story

Friday, May 27, 2016 | Medical Studies, Can-Fite BioPharma

Can-Fite Reports Provides Clinical Pipeline Update

Can-Fite BioPharma reported financial results for the three months ended March 31, 2016 and updates on its drug development programs. CF101 -- Phase 2 Glaucoma Results Expected in June; Phas…

Read the full story

Friday, May 27, 2016 | Medical Studies

ADHD: Do the Eyes Have It?

Examining the retina may aid in the diagnosis of attention-deficit/hyperactivity disorder (ADHD), new research shows. Confirming prior work, researchers observed that patients with untreated ADHD have…

Read the full story

Friday, May 27, 2016 | Acquisitions/Mergers, Valeant

Valeant Said to Have Rejected a Takeover Bid This Spring

Valeant Pharmaceuticals International received a joint takeover offer from Japan’s Takeda Pharmaceutical and TPG Capital Management this spring that the Canadian drugmaker rejected, according to…

Read the full story

Thursday, May 26, 2016 | Product Releases, MORIA

Moria Releases Single-Use Donor Vacuum Guarded Punches

Moria has extended its portfolio in endothelial graft preparation by releasing its single-use donor vacuum guarded punches. The punches safely assist corneal surgeons and/or eye bank practitioners in …

Read the full story

Thursday, May 26, 2016 | Awards, Regeneron Pharmaceuticals

Regeneron Selected by Society for Science & the Public as New Sponsor of the Science Talent Search

Society for Science & the Public announced that Regeneron Pharmaceuticals is the new title sponsor of the Science Talent Search. Selected through a competitive process that garnered interest from …

Read the full story

Thursday, May 26, 2016 | Medical Studies

Rapid Growth of E-commerce Predicted to Boost the Global Contact Lens Market Through 2020, Says Technavio

According to the latest research study released by Technavio, the global contact lens market is expected to grow at a CAGR of over 6% until 2020. The research report, titled ‘Global Contact Lens…

Read the full story

Thursday, May 26, 2016 | Conferences

5 Key Ophthalmology Takeaways: American Society of Cataract and Refractive Surgery (ASCRS) 2016

In early May, the American Society of Cataract and Refractive Surgery (ASCRS) held its annual symposium in New Orleans. As usual, the meeting was packed with new technologies and interesting studies t…

Read the full story

Thursday, May 26, 2016 | Clinical Trials, Acucela

Phase 2b/3 Clinical Trial of Acucela's Emixustat Does Not Meet Primary Endpoint

Acucela announced top-line results from the phase 2b/3 clinical trial (SEATTLE study) of the investigational visual cycle modulator emixustat hydrochloride (emixustat), according to a company news rel…

Read the full story
Load More
 Stock Price  Change 
 Aerie Pharmaceuticals, Inc. $17.87  0.00% 
 Akorn, Inc. $29.89  0.00% 
 Alimera Sciences, Inc. $1.54  0.00% 
 Allergan $235.75  0.00% 
 Avalanche Biotechnologies $4.14  0.00% 
 Bayer $95.40  0.00% 
 Can-Fite Biopharma $2.87  0.00% 
 Carl Zeiss Meditec $34.75  0.00% 
 Cooper Companies, Inc. $162.81  0.00% 
 Eleven Biotherapeutics $1.24  0.00% 
 Escalon Medical Corp. $0.85  0.00% 
 Essilor International $128.75  0.00% 
 Glaukos $24.35  0.00% 
 Imprimis Pharmaceuticals, Inc. $3.90  0.00% 
 Inotek Pharmaceuticals $9.20  0.00% 
 InSite Vision, Inc. $0.35  0.00% 
 IRIDEX Corporation $13.80  0.00% 
 Johnson & Johnson $112.69  0.00% 
 Luxottica Group, S.p.A. $54.50  0.00% 
 Merck & Company, Inc. $56.26  0.00% 
 NicOx $11.00  0.00% 
 NovaBay Pharmaceuticals, Inc. $2.94  0.00% 
 Novartis AG Common Stock $79.51  0.00% 
 Ocular Therapeutix $12.00  0.00% 
 Ophthotech Corporation $53.70  0.00% 
 QLT $1.44  0.00% 
 Quantel $3.96  0.00% 
 Regeneron $398.93  0.00% 
 Roche $32.88  0.00% 
 Second Sight Medical Products $3.90  0.00% 
 Shire $186.16  0.00% 
 STAAR Surgical Company $5.43  0.00% 
 TearLab Corporation $0.77  0.00% 
 Thrombogenics $3.45  0.00% 
 Topcon Corporation $10.38  0.00% 
 TriVascular Technologies, Inc. $5.87  0.00% 
 Valeant Pharmaceuticals $28.45  0.00% 
 Xoma $0.69  0.00%